$ITOR
Intorio, Corp.

2024 Q1 Form 10-K Financial Statement

#000168316824002917 Filed on May 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2024
Revenue $750.00 $4.850K
YoY Change -53.13% 130.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $12.11K $32.09K
YoY Change 131.99% 16.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $670.00 $2.670K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $12.11K $32.09K
YoY Change 131.99% 16.48%
Operating Profit -$27.24K
YoY Change 7.03%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$11.36K -$27.24K
YoY Change 213.81% 7.03%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$11.36K -$27.24K
YoY Change 213.81% 7.03%
Net Earnings / Revenue -1514.67% -561.59%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 3.235M shares 3.235M shares
Diluted Shares Outstanding 3.235M shares

Balance Sheet

Concept 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $920.00 $920.00
YoY Change -49.17% -49.17%
Cash & Equivalents $921.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $921.00 $920.00
YoY Change -49.12% -49.17%
LONG-TERM ASSETS
Property, Plant & Equipment $997.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $997.00 $1.000K
YoY Change -72.8% -72.75%
TOTAL ASSETS
Total Short-Term Assets $921.00 $920.00
Total Long-Term Assets $997.00 $1.000K
Total Assets $1.918K $1.920K
YoY Change -64.97% -64.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.50K $27.50K
YoY Change 27.91% 27.91%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $26.66K $26.66K
YoY Change 196.88% 196.88%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $54.16K $54.16K
YoY Change 77.68% 77.69%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $54.16K $54.16K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $54.16K $54.16K
YoY Change 77.69% 77.69%
SHAREHOLDERS EQUITY
Retained Earnings -$77.14K
YoY Change 54.58%
Common Stock $324.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$52.24K -$52.24K
YoY Change
Total Liabilities & Shareholders Equity $1.918K $1.920K
YoY Change -64.97% -64.96%

Cashflow Statement

Concept 2024 Q1 2024
OPERATING ACTIVITIES
Net Income -$11.36K -$27.24K
YoY Change 213.81% 7.03%
Depreciation, Depletion And Amortization $670.00 $2.670K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$9.190K -$18.57K
YoY Change 533.79% 10.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.200K $17.68K
YoY Change 228.0% 545.02%
NET CHANGE
Cash From Operating Activities -9.190K -$18.57K
Cash From Investing Activities
Cash From Financing Activities 8.200K $17.68K
Net Change In Cash -990.0 -$889.00
YoY Change -194.29% -93.67%
FREE CASH FLOW
Cash From Operating Activities -$9.190K -$18.57K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001852536
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-02-29
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-29
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
0177
CY2024 dei Entity Address Country
EntityAddressCountry
GE
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3235000 shares
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024 dei Auditor Name
AuditorName
Victor Mokuolu, CPA PLLC
CY2024 dei Auditor Location
AuditorLocation
Houston, Texas
CY2024 dei Auditor Firm
AuditorFirmId
6771
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
921 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1810 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
921 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1810 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8003 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5335 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
997 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3665 usd
CY2024Q1 us-gaap Assets
Assets
1918 usd
CY2023Q1 us-gaap Assets
Assets
5475 usd
CY2024Q1 NONE Due To Related Parties Current1
DueToRelatedPartiesCurrent1
26660 usd
CY2023Q1 NONE Due To Related Parties Current1
DueToRelatedPartiesCurrent1
8981 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
27500 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21500 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
54160 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
30481 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
324 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
324 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24577 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77143 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49906 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-52242 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25005 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1918 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5475 usd
CY2024 us-gaap Revenues
Revenues
4850 usd
CY2023 us-gaap Revenues
Revenues
2100 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32087 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27547 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
32087 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
27547 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
-27237 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-25447 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27237 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-25447 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3235000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3235000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
442 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-25447 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-25005 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27237 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-52242 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-27237 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-25447 usd
CY2024 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2668 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2668 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18569 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16779 usd
CY2024 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2023 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17680 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2741 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17680 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2741 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-889 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14038 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1810 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15848 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
921 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1810 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77143 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49906 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zTxFKe7ENgH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations during the reporting period, the Company made no material assumptions or estimates other than the assumption that the Company is a going concern and estimate with reference to amortization of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i></i></b></p>
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
CY2024 NONE Property Plant And Equipment Estimated Useful Lives1
PropertyPlantAndEquipmentEstimatedUsefulLives1
3 years
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8003 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5335 usd
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3235000 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3235000 shares

Files In Submission

Name View Source Status
0001683168-24-002917-index-headers.html Edgar Link pending
0001683168-24-002917-index.html Edgar Link pending
0001683168-24-002917.txt Edgar Link pending
0001683168-24-002917-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
intorio_ex3101.htm Edgar Link pending
intorio_ex3102.htm Edgar Link pending
intorio_ex3201.htm Edgar Link pending
intorio_i10k-022924.htm Edgar Link pending
MetaLinks.json Edgar Link pending
none-20240229.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
none-20240229_cal.xml Edgar Link unprocessable
intorio_i10k-022924_htm.xml Edgar Link completed
none-20240229_def.xml Edgar Link unprocessable
none-20240229_lab.xml Edgar Link unprocessable
none-20240229_pre.xml Edgar Link unprocessable